Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 24, 2012
Patent Application Number
12533935
Date Filed
July 31, 2009
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed are compounds of Formula I, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, that are useful in modulating PIKK related kinase signaling, e.g., mTOR, and for the treatment of diseases (e.g., cancer) that are mediated at least in part by the dysregulation of the PIKK signaling pathway (e.g., mTOR).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
